Supratik Sen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Supratik Sen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Dipesh
Department of Physics, GLA University, Mathura, India
6 shared publications - Sandeep Singh
Department of Radiation Oncology, Amrita School of Medicine, Amrita Vishwavidyapeetham, Faridabad, India
6 shared publications - Abhay Kumar Singh
Department of Physics, GLA University, Mathura, India
5 shared publications - Manindra Bhushan
Department of Radiation Oncology, Division of Medical Physics, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India
5 shared publications - Mahipal
Department of Physics, GLA University, Mathura, India
3 shared publications Anuj Vijay
Department of Physics, GLA University, Mathura, India
2 shared publications
Latest Publications
- 14 October 2026
- Published by Springer Nature in Health and Technology
- p. 1-9
Media exposure, misinformation and patient advocacy in cancer care: a cross-sectional survey-based study from India
- 14 October 2026
- Published by Springer Nature in Health and Technology
- p. 1-9
Media exposure, misinformation and patient advocacy in cancer care: a cross-sectional survey-based study from India
- 7 October 2026
- Published by Springer Nature in Strahlentherapie und Onkologie
- p. 1-14
Tightening the gradient: ten years of dosimetric refinement in head and neck reirradiation
- 7 October 2026
- Published by Springer Nature in Strahlentherapie und Onkologie
- p. 1-14
Tightening the gradient: ten years of dosimetric refinement in head and neck reirradiation
- 5 September 2026
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 19 (4) , 1684-1694
Site-specific performance and complexity-dependent risk assessment of patient-specific quality assurance using a 2D array detector in CyberKnife radiosurgery
- 5 September 2026
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 19 (4) , 1684-1694
Site-specific performance and complexity-dependent risk assessment of patient-specific quality assurance using a 2D array detector in CyberKnife radiosurgery
- 24 February 2026
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 49 (2) , 1-13
Bridging precision and practice: dual validation of a high-resolution detector array for beam profiling and patient QA in robotic radiosurgery
This study assessed a high-resolution ionisation chamber-based PTW 1600SRS detector array (array) for beam profile analysis and patient-specific quality assurance (PSQA) in CyberKnife (CK) stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). The goal was to determine its suitability for small fields and non-isocentric delivery, which is unique to robotic platforms. Detector performance was examined for dose linearity, reproducibility, beam profiles, output factors, dose-rate dependence, and verification of the Iris collimator field size. Results were benchmarked against diode-based commissioning data. Clinical applicability was tested by retrospectively verifying 20 intracranial SRS and 20 extracranial SBRT plans using gamma analysis with criteria ranging from 3%/3 mm to 1%/1 mm, as well as 4%/1 mm. The detector showed strong dose linearity (R2 = 0.999) and stable reproducibility. Beam profiles matched commissioning values within 0.5 mm, and output factors agreed within 2% for most collimators, with a maximum deviation of 3% at 5 mm. Dose-rate variation remained within 2.5% across relevant SADs. Iris collimator field sizes were consistent with reference measurements. Clinical validation achieved high passing rates, all with tolerance limit of > 95%. It enables accurate beam characterization and reliable PSQA in CK treatments. This work provides the first combined evaluation of beam analysis and clinical validation for this detector on a robotic radiosurgery system, supporting its routine use in small-field quality assurance.
- 24 February 2026
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 49 (2) , 1-13
Bridging precision and practice: dual validation of a high-resolution detector array for beam profiling and patient QA in robotic radiosurgery
This study assessed a high-resolution ionisation chamber-based PTW 1600SRS detector array (array) for beam profile analysis and patient-specific quality assurance (PSQA) in CyberKnife (CK) stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). The goal was to determine its suitability for small fields and non-isocentric delivery, which is unique to robotic platforms. Detector performance was examined for dose linearity, reproducibility, beam profiles, output factors, dose-rate dependence, and verification of the Iris collimator field size. Results were benchmarked against diode-based commissioning data. Clinical applicability was tested by retrospectively verifying 20 intracranial SRS and 20 extracranial SBRT plans using gamma analysis with criteria ranging from 3%/3 mm to 1%/1 mm, as well as 4%/1 mm. The detector showed strong dose linearity (R2 = 0.999) and stable reproducibility. Beam profiles matched commissioning values within 0.5 mm, and output factors agreed within 2% for most collimators, with a maximum deviation of 3% at 5 mm. Dose-rate variation remained within 2.5% across relevant SADs. Iris collimator field sizes were consistent with reference measurements. Clinical validation achieved high passing rates, all with tolerance limit of > 95%. It enables accurate beam characterization and reliable PSQA in CK treatments. This work provides the first combined evaluation of beam analysis and clinical validation for this detector on a robotic radiosurgery system, supporting its routine use in small-field quality assurance.
- 11 September 2025
- Published by Elsevier in Clinical Oncology
- Vol. 47, 103936
Optimization and Quality Assurance of VMAT-Driven Lattice Radiotherapy in Large Tumors Across Anatomical Sites
- 11 September 2025
- Published by Elsevier in Clinical Oncology
- Vol. 47, 103936
Optimization and Quality Assurance of VMAT-Driven Lattice Radiotherapy in Large Tumors Across Anatomical Sites
- 18 August 2025
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 18 (4) , 1055-1063
Impact of dynamic jaw width adjustment in tomotherapy on hippocampus sparing and treatment efficiency in whole-brain radiotherapy
The aim of this study is to evaluate the impact of dynamic jaw width adjustment in tomotherapy on hippocampal sparing, target dose conformity, and treatment efficiency in hippocampal-avoidance whole-brain radiotherapy (HA-WBRT), in accordance with RTOG 0933 guidelines. A retrospective study of 60 patients treated with HA-WBRT was conducted. CT-MRI fusion facilitated accurate hippocampal delineation. Treatment plans were created using Accuray Precision TPS and delivered on the Radixact Tomotherapy system with three jaw widths (1 cm, 2.5 cm, and 5 cm), fixed pitch (0.215), and modulation factor (3.0). The prescription dose was 30 Gy in 10 fractions. Evaluation metrics included PTV coverage (D98%, V95%, D2%, Dmax), homogeneity index (HI), conformity index (CI), hippocampal and lens doses, and beam-on time (BOT). Plan verification was performed with ArcCHECK using 3%/3 mm and 3%/2 mm gamma criteria. The 1 cm jaw achieved the best PTV coverage (D98% = 29.22 Gy, V95% = 98.71%), with HI = 0.09, CI = 0.99, and superior hippocampal sparing (Dmax = 14.91 Gy, Dmin = 7.57 Gy), but had the longest BOT (1165 s). Wider jaws (2.5 cm, 5 cm) reduced BOT (480 s, 280 s) but slightly compromised conformity and increased OAR doses, all within limits. Jaw width selection in Helical Tomotherapy influences dose distribution characteristics and treatment delivery efficiency in hippocampus-sparing WBRT. A 1 cm jaw width provides superior dosimetric conformity and enhanced hippocampal sparing, albeit at the cost of increased BOT. In contrast, wider jaw widths (2.5 cm and 5 cm) improve delivery efficiency but result in modest reductions in dose precision and organ-at-risk sparing. Therefore, jaw width selection should be carefully individualized based on clinical objectives, balancing the trade-off between organ preservation and treatment efficiency.
- 18 August 2025
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 18 (4) , 1055-1063
Impact of dynamic jaw width adjustment in tomotherapy on hippocampus sparing and treatment efficiency in whole-brain radiotherapy
The aim of this study is to evaluate the impact of dynamic jaw width adjustment in tomotherapy on hippocampal sparing, target dose conformity, and treatment efficiency in hippocampal-avoidance whole-brain radiotherapy (HA-WBRT), in accordance with RTOG 0933 guidelines. A retrospective study of 60 patients treated with HA-WBRT was conducted. CT-MRI fusion facilitated accurate hippocampal delineation. Treatment plans were created using Accuray Precision TPS and delivered on the Radixact Tomotherapy system with three jaw widths (1 cm, 2.5 cm, and 5 cm), fixed pitch (0.215), and modulation factor (3.0). The prescription dose was 30 Gy in 10 fractions. Evaluation metrics included PTV coverage (D98%, V95%, D2%, Dmax), homogeneity index (HI), conformity index (CI), hippocampal and lens doses, and beam-on time (BOT). Plan verification was performed with ArcCHECK using 3%/3 mm and 3%/2 mm gamma criteria. The 1 cm jaw achieved the best PTV coverage (D98% = 29.22 Gy, V95% = 98.71%), with HI = 0.09, CI = 0.99, and superior hippocampal sparing (Dmax = 14.91 Gy, Dmin = 7.57 Gy), but had the longest BOT (1165 s). Wider jaws (2.5 cm, 5 cm) reduced BOT (480 s, 280 s) but slightly compromised conformity and increased OAR doses, all within limits. Jaw width selection in Helical Tomotherapy influences dose distribution characteristics and treatment delivery efficiency in hippocampus-sparing WBRT. A 1 cm jaw width provides superior dosimetric conformity and enhanced hippocampal sparing, albeit at the cost of increased BOT. In contrast, wider jaw widths (2.5 cm and 5 cm) improve delivery efficiency but result in modest reductions in dose precision and organ-at-risk sparing. Therefore, jaw width selection should be carefully individualized based on clinical objectives, balancing the trade-off between organ preservation and treatment efficiency.